Allison D. Ebert

4.8k total citations · 1 hit paper
65 papers, 3.4k citations indexed

About

Allison D. Ebert is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Allison D. Ebert has authored 65 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 27 papers in Genetics and 16 papers in Cellular and Molecular Neuroscience. Recurrent topics in Allison D. Ebert's work include Neurogenetic and Muscular Disorders Research (24 papers), Pluripotent Stem Cells Research (18 papers) and RNA modifications and cancer (15 papers). Allison D. Ebert is often cited by papers focused on Neurogenetic and Muscular Disorders Research (24 papers), Pluripotent Stem Cells Research (18 papers) and RNA modifications and cancer (15 papers). Allison D. Ebert collaborates with scholars based in United States, Switzerland and Italy. Allison D. Ebert's co-authors include Clive N. Svendsen, Christian L. Lorson, Virginia B. Mattis, Ferrill F. Rose, James A. Thomson, Junying Yu, Jered V. McGivern, Samantha L. Sison, Andrew J. Schwab and Teresa N. Patitucci and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Neuron.

In The Last Decade

Allison D. Ebert

65 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Induced pluripotent stem cells from a spinal muscular atrophy patient

2008 1.1k citations Allison D. Ebert, Virginia B. Mattis et al. profile →

Peers

Countries citing papers authored by Allison D. Ebert

Since Specialization

Citations

This map shows the geographic impact of Allison D. Ebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison D. Ebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison D. Ebert more than expected).

Fields of papers citing papers by Allison D. Ebert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison D. Ebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison D. Ebert. The network helps show where Allison D. Ebert may publish in the future.

Co-authorship network of co-authors of Allison D. Ebert

This figure shows the co-authorship network connecting the top 25 collaborators of Allison D. Ebert. A scholar is included among the top collaborators of Allison D. Ebert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allison D. Ebert. Allison D. Ebert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	IL-1ra and CCL5, but not IL-10, are promising targets for treating SMA astrocyte-driven pathology 2024 ·Molecular Therapy ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Matthew Harmelink, Barrington G. Burnett, Allison D. Ebert	1
2	Human cytomegalovirus induces significant structural and functional changes in terminally differentiated human cortical neurons 2023 ·mBio ·(unknown), (unknown), (unknown), (unknown), Scott S. Terhune, Allison D. Ebert	8
3	Neutralizing antibodies with neurotropic factor treatment maintain neurodevelopmental gene expression upon exposure to human cytomegalovirus 2023 ·Journal of Virology ·(unknown), (unknown), (unknown), (unknown), Scott S. Terhune, Allison D. Ebert	2
4	Detection of Soluble and Insoluble Protein Species in Patient-Derived iPSCs 2022 ·Methods in molecular biology ·(unknown), (unknown), Allison D. Ebert	3
5	Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models 2019 ·Comprehensive physiology ·Sarah Logan, Thiago Arzua, Scott G. Canfield, (unknown), Samantha L. Sison, Allison D. Ebert, Xiaowen Bai	6
6	SRCP1 Conveys Resistance to Polyglutamine Aggregation 2018 ·Molecular Cell ·(unknown), (unknown), Adam J. Kanack, (unknown), Samantha L. Sison, (unknown), (unknown), (unknown), R. Blake Hill, Brian A. Link, Allison D. Ebert, K. Matthew Scaglione	13
7	Self-oligomerization regulates stability of survival motor neuron protein isoforms by sequestering an SCF ^Slmb degron 2017 ·Molecular Biology of the Cell ·Kelsey M. Gray, (unknown), David Baillat, Ying Wen, Thomas Bonacci, Allison D. Ebert, Amanda C. Raimer, (unknown), Sara ten Have, Jacqueline Glascock, Kushol Gupta, Gregory D. Van Duyne, Michael J. Emanuele, Angus I. Lamond, Eric J. Wagner, Christian L. Lorson, A. Gregory Matera	24
8	Decreased Sirtuin Deacetylase Activity in LRRK2 G2019S iPSC-Derived Dopaminergic Neurons 2017 ·Stem Cell Reports ·Andrew J. Schwab, Samantha L. Sison, (unknown), Katarzyna A. Broniowska, John A. Corbett, Allison D. Ebert	69
9	Astrocyte-produced miR-146a as a mediator of motor neuron loss in spinal muscular atrophy 2017 ·Human Molecular Genetics ·Samantha L. Sison, Teresa N. Patitucci, (unknown), Eric Villalón, Christian L. Lorson, Allison D. Ebert	62
10	Optimization of Morpholino Antisense Oligonucleotides Targeting the Intronic Repressor Element1 in Spinal Muscular Atrophy 2016 ·Molecular Therapy ·Erkan Y. Osman, (unknown), (unknown), (unknown), Teresa N. Patitucci, (unknown), (unknown), Chien‐Ping Ko, Allison D. Ebert, Christian L. Lorson	26
11	Neurite Aggregation and Calcium Dysfunction in iPSC-Derived Sensory Neurons with Parkinson’s Disease-Related LRRK2 G2019S Mutation 2015 ·Stem Cell Reports ·Andrew J. Schwab, Allison D. Ebert	70
12	Targeted disruption of Tbc1d20with zinc-finger nucleases causes cataracts and testicular abnormalities in mice 2014 ·BMC Genetics ·(unknown), (unknown), (unknown), Allison D. Ebert, Aron M. Geurts, D.J. Sidjanin	19
13	Exploiting pluripotent stem cell technology for drug discovery, screening, safety, and toxicology assessments 2013 ·Advanced Drug Delivery Reviews ·Jered V. McGivern, Allison D. Ebert	19
14	Chromosome 7 and 19 Trisomy in Cultured Human Neural Progenitor Cells 2009 ·PLoS ONE ·Dhruv Sareen, Erin McMillan, Allison D. Ebert, Brandon Shelley, Julie A. Johnson, Lorraine F. Meisner, Clive N. Svendsen	55
15	Response of aged parkinsonian monkeys to in vivo gene transfer of GDNF 2009 ·Neurobiology of Disease ·Marina E. Emborg, Jeffrey M. Moirano, (unknown), Viktoriya Bondarenko, Romain Zufferey, (unknown), Allison D. Ebert, Valerie Joers, Ben Roitberg, J. E. Holden, James B. Koprich, Jack W. Lipton, Jeffrey H. Kordower, Patrick Aebischer	39
16	Delivery of a read-through inducing compound, TC007, lessens the severity of a spinal muscular atrophy animal model 2009 ·Human Molecular Genetics ·Virginia B. Mattis, Allison D. Ebert, Marina Y. Fosso, Cheng‐Wei Tom Chang, Christian L. Lorson	77
17	Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease 2007 ·Experimental Neurology ·Allison D. Ebert, Amy Beres, Amelia E. Barber, Clive N. Svendsen	129
18	A New Tool in the Battle Against Alzheimer's Disease and Aging: Ex Vivo Gene Therapy 2005 ·Rejuvenation Research ·Allison D. Ebert, Clive N. Svendsen	16
19	Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates 2005 ·Gene Therapy ·Soshana Behrstock, Allison D. Ebert, Jacalyn McHugh, (unknown), (unknown), Bernard L. Schneider, Elizabeth E. Capowski, Derek J. Hei, Jeffrey H. Kordower, Patrick Aebischer, Clive N. Svendsen	131
20	A tetracycline-regulated adenovirus encoding dominant-negative caspase-9 is regulated in rat brain and protects against neurotoxin-induced cell death in vitro, but not in vivo 2004 ·Experimental Neurology ·Allison D. Ebert, Feng Chen, Xiaolong He, Vincent L. Cryns, Martha C. Bohn	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact